Neurobiological Elements of Cognitive Dysfunction in Down Syndrome: Exploring the Role of APP

作者: Martha Millan Sanchez , Sietske N. Heyn , Devsmita Das , Sarah Moghadam , Kara J. Martin

DOI: 10.1016/J.BIOPSYCH.2011.08.016

关键词: NeuroscienceDown syndromeHippocampusLocus coeruleusHippocampal formationDegeneration (medical)Amyloid precursor proteinCholinergicPsychologyNeurodegeneration

摘要: Down syndrome (DS) is the most common cause of cognitive dysfunction in children. Additionally, adults with DS will eventually show both clinical and neuropathologic hallmarks Alzheimer's disease (AD). The hippocampal formation constitutes primary target for degeneration AD DS. Over past few years, we have studied molecular mechanisms behind this region its major inputs mouse models Our investigation has suggested that loss inputs, particularly cholinergic noradrenergic terminals, leads to de-afferentation Ts65Dn model Interestingly, were able link overexpression amyloid precursor protein (App) gene neurons models. We examined underlying multiple systems extensive projections hippocampus role App neurodegeneration. Understanding helped us test several therapeutic strategies successfully Here review these discuss ways translate our findings into possible interventions humans.

参考文章(95)
R. Weitzdoerfer, M. Dierssen, M. Fountoulakis, G. Lubec, Fetal life in Down Syndrome starts with normal neuronal density but impaired dendritic spines and synaptosomal structure Journal of Neural Transmission-supplement. pp. 59- 70 ,(2001) , 10.1007/978-3-7091-6262-0_5
Chan Ch, Leung Sy, Hui Hn, Ng Dk, Cheung Jm, Chow Py, Kwok Kl, Obstructive sleep apnoea in children with Down syndrome. Singapore Medical Journal. ,vol. 47, pp. 774- 779 ,(2006)
Jason Lockrow, Heather Boger, Greg Gerhardt, Gary Aston-Jones, David Bachman, Ann-Charlotte Granholm, A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model. Journal of Alzheimer's Disease. ,vol. 23, pp. 471- 489 ,(2011) , 10.3233/JAD-2010-101218
Wan Ariffin Bin Abdullah, Singapore Med J ,(1993)
Delilah T. White, Michelle A. Melyn, Mental and developmental milestones of noninstitutionalized Down's syndrome children. Pediatrics. ,vol. 52, pp. 542- 545 ,(1973)
Giuliana Miolo, Robin S. Chapman, Heidi A. Sindberg, Sentence Comprehension in Adolescents With Down Syndrome and Typically Developing Children: Role of Sentence Voice, Visual Context, and Auditory-Verbal Short-Term Memory Journal of Speech Language and Hearing Research. ,vol. 48, pp. 172- 188 ,(2005) , 10.1044/1092-4388(2005/013)
Kangning Liu, Ingrid Solano, David Mann, Cynthia Lemere, Marc Mercken, John Q. Trojanowski, Virginia M.-Y. Lee, Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease. Acta Neuropathologica. ,vol. 112, pp. 163- 174 ,(2006) , 10.1007/S00401-006-0077-5
E. C. Downes, J. Robson, E. Grailly, Z. Abdel-All, J. Xuereb, C. Brayne, A. Holland, W. G. Honer, E. B. Mukaetova-Ladinska, Loss of synaptophysin and synaptosomal-associated protein 25-kDa (SNAP-25) in elderly Down syndrome individuals. Neuropathology and Applied Neurobiology. ,vol. 34, pp. 12- 22 ,(2007) , 10.1111/J.1365-2990.2007.00899.X
Anne Rovelet-Lecrux, Didier Hannequin, Gregory Raux, Nathalie Le Meur, Annie Laquerrière, Anne Vital, Cécile Dumanchin, Sébastien Feuillette, Alexis Brice, Martine Vercelletto, Frédéric Dubas, Thierry Frebourg, Dominique Campion, APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy Nature Genetics. ,vol. 38, pp. 24- 26 ,(2006) , 10.1038/NG1718
A. Salehi, J.-D. Delcroix, D. F. Swaab, Alzheimer's disease and NGF signaling. Journal of Neural Transmission. ,vol. 111, pp. 323- 345 ,(2004) , 10.1007/S00702-003-0091-X